Cerebral Inc., a fast-growing mental health and medication management startup based in San Francisco, recently announced it will stop prescribing most controlled substances to new patients starting this Friday....
Medical care for individuals with autism spectrum disorder (ASD) has long faced significant gaps in accessibility, understanding, and effectiveness. While many behavioral therapies like...
While financial details of the transaction were not disclosed, the acquisition signals a strategic push by Stepping Stones to broaden its footprint in the...
In 2020, the autism treatment market stood on the edge of a major transformation. While representing one of the smallest sub-sectors in behavioral health...
In recent years, private equity (PE) firms have shown significant interest in behavioral health care, but no niche has seen more explosive growth than...
In recent years, private equity’s appetite for behavioral health has grown substantially—but few sectors have seen as dramatic a rise in interest as autism...
When it comes to autism, the conversation tends to focus primarily on children. Public discourse, resources, and services have long been geared toward helping...